← Eichor
Condition: Antibody Deficiency Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antibody Deficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
NA · 1 location(s) · University Hospital, Motol · NCT06497829RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Phase 1 · 1 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT06484335PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05236972Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961Effective Dosing of Burosumab in XLH
Phase N/A · 1 location(s) · University of Nottingham · NCT07183579Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy
Phase N/A · 1 location(s) · University of Alberta · NCT06989541Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT05193552Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
Phase N/A · 1 location(s) · Duke University · NCT01665326Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Phase 1/Phase 2 · 1 location(s) · West China Hospital · NCT04636008Multiplo Tp/HIV Self-Test
NA · 3 location(s) · Unity Health Toronto · NCT06716450Exercise Intervention and Immunodeficiency
NA · 2 location(s) · Yale University · NCT07698197Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Phase 3 · 12 location(s) · Biopharma Plasma LLC · NCT07346859Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors
Phase 2 · 30 location(s) · BeiGene · NCT03736889IVIG vs SCIG in CIDP
Phase 1 · 1 location(s) · Rutgers, The State University of New Jersey · NCT05584631Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic
Phase 3 · 5 location(s) · Grifols Biologicals, LLC · NCT07582432Frequency of SPAD in Adult Patients
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05664035Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Phase N/A · 1 location(s) · University of Zimbabwe · NCT07195006Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT07135427This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasm
Phase N/A · 6 location(s) · American Laboratory Products Company · NCT07089836177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
EARLY_Phase 1 · 5 location(s) · Radiopharm Theranostics, Ltd · NCT06305962V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · 1 location(s) · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2 · 12 location(s) · Imperial College London · NCT04319367EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Eisbach Bio GmbH · NCT06525298National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06976476Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
Phase 2 · 1 location(s) · Peking University · NCT06580574
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.